![]() |
| A reliable partner of leading pharmaceutical manufacturers in Japan and elsewhere, Nisso supplies innovative pharmaceuticals and
intermediates, whose development and production is based on organic synthesis
technology. In recent years the company has achieved pioneering work in the pharmaceutical industry: Nisso became the first company in the world to develop technology for mass-producing AOSA (acetoxyacetythinone), an intermediate for penem and carbapenem antibiotics. Shipment began in 1991. Not only that, it is the only Japanese company to manufacture HPC (hydroxypropyl cellulose). Nisso's efforts to develop high-quality pharmaceuticals and intermediates, including those for new medicines, contributes to the world's pharmaceutical industry. |
![]() |






